Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
India Field Epidemiology Training Program Response to COVID-19 Pandemic, 2020-2021.
Singh SK, Dikid T, Dhuria M, Bahl A, Chandra R, Pradeep VT, Prajapati SM, Nirwan N, Paul L, Murhekar M, Kaur P, Parasuraman G, Bhat P, Longkumer S, Dzeyie KA, Bhatnagar P, Minh NNT, Tanwar S, Yadav R, Desai M. Singh SK, et al. Among authors: bahl a. Emerg Infect Dis. 2022 Dec;28(13):S138-S144. doi: 10.3201/eid2813.220563. Emerg Infect Dis. 2022. PMID: 36502396 Free PMC article. Review.
Clinical and Epidemiological Characteristics of Mpox Cases Identified Through Case-based Surveillance in India, July 2022-January 2023.
Kuriakose S, Gupta RK, Kumar A, Kumar J, Kulkarni S, Chauhan H, Relhan V, Meenakshy V, Gopalakrishnan LG, Singh SK, Bahl A, Tanwar S, Dikid T. Kuriakose S, et al. Among authors: bahl a. Indian J Public Health. 2024 Jul 1;68(3):374-379. doi: 10.4103/ijph.ijph_1381_23. Epub 2024 Sep 24. Indian J Public Health. 2024. PMID: 39321225 Free article.
Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations.
Rebuzzi SE, Ghose A, Rudman S, Venugopal B, Young K, Frazer RD, Ayodele O, Stares M, O'Carrigan B, Ali W, McGrane J, Jain A, Fiala O, Chauhan V, Michael A, Zarkar A, Kapur G, Charnley N, Afshar M, Vengalil S, Forde C, Brown J, Urun Y, Bianchini D, Bahl A, Srihari N, Di Costanzo F, Smalley B, Parkes J, Crabb S, Vasudev N, Poprach A, Brown N, James L, Haywood S, Tapia J, Vijay A, Parry J, Cheung M, Mahajan I, Moon NO, Abrol R, Tkadlecová M, Yee Soe YS, Zargham A, Smith M, Ashley S, Hardy O, Patel G, Tun KK, Johnston E, Sarwer A, Bölek H, Shrestha R, Challapalli A, Meegan J, Anpalakhan S, Buono F, Kolarikova E, Leung DK, Murianni V, Catalano F, Bimbatti D, Buti S, Signori A, Fornarini G, Rescigno P, Chun Teoh JY, Banna GL. Rebuzzi SE, et al. Among authors: bahl a. Oncologist. 2026 May 20:oyag203. doi: 10.1093/oncolo/oyag203. Online ahead of print. Oncologist. 2026. PMID: 42159577 Free article.
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials.
Kayani M, Murphy L, Dutey-Magni P, Howlett S, Sachdeva A, Padden-Modi M, Abdel-Aty H, Brown LC, Amos CL, Chan K, Gilbert DC, Langley RE, Brown M, Sydes MR, Parker CC; STAMPEDE Collaborators; Cross W, Malik Z, Varughese M, Turco F, Millman R, Matheson D, Gillessen S, Clarke NW, Parmar MKB, James ND, Attard G. Kayani M, et al. Lancet Oncol. 2026 May;27(5):625-636. doi: 10.1016/S1470-2045(26)00066-5. Lancet Oncol. 2026. PMID: 42061373 Free article. Clinical Trial.
683 results